Future perspectives in melanoma research. Meeting report from the “Melanoma Bridge. Napoli, December 2nd-4th 2012”
Paolo A. Ascierto(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Luana Calabrò(University of Siena), Giuseppe Palmieri(University of Sassari), Ahmad A. Tarhini(UPMC Hillman Cancer Center), Roger S. Lo(University of California, Los Angeles), Soldano Ferrone(Massachusetts General Hospital), Barbara Seliger(Luther University), Peter Suenaert(GlaxoSmithKline (Belgium)), Cornelis J.M. Melief(ISA Pharmaceuticals (Netherlands)), Antonio Maria Grimaldi(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Grant A. McArthur(The University of Melbourne), Alberto Mantovani(Humanitas University), Igor Puzanov(Roswell Park Comprehensive Cancer Center), Ena Wang(Sidra Medical and Research Center), Alessandra Cesano(Nanostring Technologies (United States)), Alexander M.M. Eggermont(University Medical Center Utrecht), Gennaro Ciliberto(Istituti Fisioterapici Ospitalieri), Nicolas Acquavella(National Institutes of Health), Lorenzo Borgognoni(Tumour Institute of Tuscany), Francesco M. Marincola(Center for Translational Molecular Medicine), Fernando Vidal‐Vanaclocha(George Washington University), Bernard A. Fox(Oregon Health & Science University), Jérôme Galon(Délégation Paris 5), James Larkin(Trinity College Dublin), Sacha Gnjatic(Tisch Hospital), Mohammed Kashani–Sabet(California Pacific Medical Center), Mark B. Faries(Angeles Clinic and Research Institute), Giorgio Trinchieri(National Cancer Institute), Antoni Ribas(University of California, Los Angeles), Kim Margolin(City Of Hope National Medical Center), Thomas F. Gajewski(University of Chicago), Helen Gogas(National and Kapodistrian University of Athens), Howard L. Kaufman(Rutgers, The State University of New Jersey), Natale Cascinelli, Jeff Sosman, Michele Del Vecchio(Fondazione IRCCS Istituto Nazionale dei Tumori), Nicola Mozzillo(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale")
Cited by 18
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
The chemokine system in diverse forms of macrophage activation and polarization
|Trends in Immunology|2004|6.5k
Pembrolizumab versus Ipilimumab in Advanced Melanoma
|New England Journal of Medicine|2015|5.9k